Chemotherapy gadgets: an interview with Damien Salauze.

The three-year initial partnership between Curie-Malignancy and Vygon has been extended. What do you desire to obtain from the extension of the set up? Related StoriesCornell biomedical engineers develop 'super organic killer cells' to destroy malignancy cells in lymph nodesNew antenna-like device makes breasts cancer surgery easier for surgeonsNew RNA test of blood platelets may be used to detect location of cancer The extension period covers completion of the development of the coating treatment that I mentioned previously, then your initiation of completely different research on a totally different range of products with a totally different technology. How long do you think it will take to bring the new range of items to the international marketplace? I anticipate it to be up to a few years but it could be months.We’re causing much less suffering. We aren’t putting these animals through the experience to be enslaved in something with the sole purpose of turning their body into a food source and, ultimately, a profit source. Let’s encounter it – – that’s what cattle ranching and pig farming and poultry farming is certainly today. It’s something of exploiting the lives of these animals to make a profit. So if artificial meats can replace that, that’s an important benefit. Let customers eat meat without needing to kill animals.